Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model

References

• Antonovych TT. 1981. Gold nephropathy. Ann Clin Lab Sci 11(5):386–391.
   PubMedGoogle Scholar
• Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5(16):1897–910.
   PubMedGoogle Scholar
• Cherukuri P, Glazer ES, Curley SA. 2009. Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62(3):339–345.
   Google Scholar
• Chien AJ, Illi JA, Ko AH, Kom WM, Fong L, Chen LM, 2009. A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies. Clin Cancer Res 15(17):5569–5575.
   PubMedGoogle Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662–668.
   PubMed Web of Science ®Google Scholar
• Curley SA, Cherukuri P, Briggs K, Patra CR, Upton M, Dolson E 2008. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J Exp Ther Oncol 7(4):313–326.
   PubMedGoogle Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12):1912–1919.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Ferrari M. 2008. The receptor-mediated endocytosis of nonspherical particles. Biophys J 94(10):3790–3797.
   PubMedGoogle Scholar
• Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ. 2009. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 131(41):14652–14653.
   PubMed Web of Science ®Google Scholar
• Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A. 1976. Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis 35(3):251–257.
   PubMedGoogle Scholar
• Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kanzius JS, Kittrell C, 2007. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110(12):2654–2665.
   PubMedGoogle Scholar
• Glazer ES, Curley SA. 2010. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer 116(13):3285–3293.
   PubMedGoogle Scholar
• Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156(4):1363–1380.
   PubMed Web of Science ®Google Scholar
• Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, 2002. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8(5):1038–1044.
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40(4):328–346.
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves C, Gonzalez-Romero D, 2010. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393(4):649–655.
   PubMedGoogle Scholar
• Luo W, Zhou X, Zheng X, He G, Yu M, Li Q, 2009. Role of sonography for implantation and sequential evaluation of a VX2 rabbit liver tumor model. J Ultrasound Med 29(1):51–60.
   Google Scholar
• Milacic V, Fregona D, Dou QP. 2008. Gold complexes as prospective metal-based anticancer drugs. Histol Histopathol 23(1):101–108.
   PubMedGoogle Scholar
• Sadauskas E, Danscher G, Stoltenberg M, Vogel D, Larsen A, Wallin H. 2009. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5(2):162–169.
   PubMedGoogle Scholar
• Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10.
   PubMedGoogle Scholar
• Shope RE, Hurst EW. 1933. Infectious papillomatosis of rabbits: With a note on the histopathology. J Exp Med 58(5):607–624.
   PubMedGoogle Scholar
• Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B Biointerfaces 66(2):274–280.
   PubMed Web of Science ®Google Scholar
• Sukumar M, Doyle BL, Combs JL, Pekar AH. 2004. Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association. Pharm Res 21(7):1087–1093.
   PubMedGoogle Scholar
• Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. 2009. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res 69(22):8784–8789.
   PubMed Web of Science ®Google Scholar
• Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F, 2006. Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22(8):673–685.
   PubMedGoogle Scholar